BGPT: Paper Review: Tamm-Horsfall Protein Regulates Granulopoiesis and Systemic Neutrophil Homeostasis

Explore by Goal

Quick Answer Copied

Core claim

THP (uromodulin) deficiency in mice produces systemic neutrophilia via a renal IL-23→IL-17→G-CSF pathway, with IL-23 driven by S3 proximal tubular epithelium.

Evidence anchors: neutrophils increase in kidney/liver/blood; bone marrow shows altered granulopoiesis; IL-17 neutralization reverses neutrophilia; kidney (not liver) shows increased IL-17 and IL-23; LMD/FACS localizes IL-23 to S3 segments.

Long Answer

Paper Review (skeptical, evidence-based)

Tamm-Horsfall Protein Regulates Granulopoiesis and Systemic Neutrophil Homeostasis

DOI: 10.1681/ASN.2014070664 • (J Am Soc Nephrol, 2015 as provided)

Mechanism proposed Renal IL-23/IL-17 → bone-marrow granulopoiesis

Visual: causal chain the authors support

1) THP deficiency

THP−/− mice show increased neutrophils in kidney and beyond.

2) Kidney-enriched IL-17

IL-17 (and IL-23) are elevated in kidney extracts but not liver in the multiplex screen.

3) IL-17 is causal (in vivo)

Neutralizing IL-17 reverses systemic and renal neutrophilia and lowers serum G-CSF.

4) IL-23 source mapped to S3

LMD + FACS suggests S3 proximal tubular segments are the major IL-23-producing compartment in THP−/− kidneys.

Evidence map (what each experiment really pins down)

Claim being tested	Assay/analysis in paper	What it supports	Key uncertainty / skeptical check
THP deficiency causes neutrophilia (kidney + systemic)	GR1 immunohistochemistry; flow cytometry (CD45+CD11b+Ly6G+); CBC-like analyzer for peripheral counts	Neutrophils increase in kidney and also in liver/spleen; peripheral neutrophils increase in THP−/− mice.	Flow gating defines “neutrophil” by markers; without additional functional validation, phenotype-to-function causality remains partly inferred.
Systemic neutrophilia reflects enhanced granulopoiesis	Bone marrow flow cytometry for progenitors (e.g., CMP/GMP) and differentiated Ly6G+ neutrophils; serum G-CSF by ELISA	Reports decreased granulocyte progenitors but increased differentiated neutrophils; serum G-CSF increases in THP−/−.	Progenitor decreases can be consistent with differentiation acceleration, but also could reflect altered survival/redistribution—bone-marrow functional assays would strengthen the causal inference.
Kidney produces the critical granulopoietic cytokines	Multiplex ELISA (32 cytokines/chemokines) on kidney vs liver extracts	IL-17 (and CXCL2, CXCL9, etc.) increases in kidneys of THP−/− but not liver in the multiplex panel.	Multiplex is descriptive: “increased” doesn’t prove causality. The authors do move toward causality with IL-17 neutralization (below), but other analytes could contribute.
IL-17 is necessary for systemic neutrophilia in THP−/−	In vivo anti-IL-17 mAb neutralization; measure peripheral/renal neutrophils + serum G-CSF	IL-17 neutralization reverses neutrophilia and reduces serum G-CSF.	Neutralizing IL-17 shows necessity for the phenotype as measured, but doesn’t define whether IL-17 is upstream of all relevant drivers or one of multiple converging paths.
IL-23 is the upstream inducer in the kidney	Real-time PCR and ELISA for IL-23 in kidney; assess serum IL-23	THP−/− kidneys show increased IL-23 mRNA and protein; IL-23 not detected in serum.	IL-23 upstreamness is supported by pathway logic and increased IL-23, but the paper excerpt does not show IL-23 neutralization/epistasis tests in THP−/− (that would be the cleanest necessity test).
IL-23 comes from a specific renal epithelial compartment (S3)	LMD dissection of nephron segments + FACS isolation of immune cells; IL-23 mRNA across compartments	S3 segments uniquely show IL-23 mRNA upregulation in THP−/−; not found in macrophages/dendritic cells, T cells, glomeruli, S1-S2, or TAL in their panel.	mRNA detection depends on RNA yield and assay sensitivity; the paper notes difficulty amplifying IL-17 mRNA reliably. Similar technical limitations could affect compartment conclusions (false negatives in compartments).

What is known vs inferred vs uncertain (explicit)

Known from the paper (direct measurements)

THP−/− mice have increased neutrophils in kidney and also increased neutrophils in other organs (e.g., liver, spleen) and in peripheral blood.
THP−/− bone marrow shows an altered granulocyte progenitor/differentiation profile and increased serum G-CSF.
Kidney (not liver) multiplex profiling shows increased IL-17 (and other analytes); ELISA shows increased serum IL-17; IL-17 neutralization reverses neutrophilia.
Renal IL-23 is increased at the mRNA and protein levels in THP−/−; serum IL-23 is not detected.

Inferred by the authors (requires additional direct epistasis to be fully decisive)

The IL-23/IL-17 axis explains systemic neutrophilia—supported by pathway consistency and IL-17 neutralization, but IL-23 necessity (e.g., IL-23 neutralization in THP−/−) is not shown in the provided excerpt.
S3 epithelial cells are the major functional driver of IL-23—supported by IL-23 mRNA localization, but mRNA detection limits can affect compartment “absence” calls.

Uncertain / missing information from what we received

Whether changes persist across different housing conditions, microbiome states, sexes, or ages (only 8–12 week male/female not specified in excerpt).
The relative contribution of any other cytokines altered in the multiplex panel (multiple analytes change; only IL-17 neutralization is shown as sufficient/necessary for the phenotype as measured).

Quantitative figure reproduction note

The provided content includes figure captions but not the underlying numeric data points needed to faithfully reconstruct the paper’s plots with Plotly (e.g., per-analyte standardized mean differences in Figure 4, or exact bar heights). Therefore, I’m not generating Plotly charts from non-existent raw numbers, to avoid misleading “fake precision”.

Mechanistic critique (skeptical review)

Strong causal anchor: IL-17 neutralization reverses the neutrophilia phenotype and lowers serum G-CSF, which makes IL-17 more than a correlational marker in the THP−/− setting.
Pathway incompleteness: The IL-23 upstream role is supported (kidney IL-23 up; serum IL-23 not detected), but the cleanest upstream necessity test—IL-23 neutralization or direct IL-23 blockade in THP−/−—is not evidenced in the excerpt you provided.
Compartmental inference limitations: LMD/FACS localization is powerful, but “no detection” can reflect sensitivity limits. The authors explicitly report difficulty detecting IL-17 mRNA reliably (implying the broader practical reality that transcript detection can be challenging in their system).
Multiple analytes moved: Multiplex ELISA indicates other chemokines/cytokines change too (example: IL-17, CXCL2, CXCL9 are increased in kidney extracts). The paper’s mechanistic emphasis on IL-17 is justified by neutralization, but remaining contributors to granulopoiesis could exist.

Counterfactuals: what would disprove the main model?

If THP−/− neutrophilia persists despite IL-17 neutralization, the IL-17 necessity claim would fail.
If IL-23 blockade eliminates the phenotype less than IL-17 blockade (or not at all), then the upstream IL-23→IL-17 logic would need revision (possibly alternative IL-17 inducers).
If S3-targeted IL-23 reduction (rather than whole-kidney effects) fails to reduce IL-17/G-CSF/neutrophilia, then the “S3 is the major source” localization would be incomplete or secondary.

Author-review deep links (all full names listed in provided TEI)

Feedback:

Updated: April 10, 2026